Lexeotx
VerifiedWork at Lexeotx.
Lexeo Therapeutics is a clinical-stage genetic medicine company developing AAV-based gene therapies for cardiovascular diseases and APOE4-associated Alzheimer's disease. Its lead candidate, LX2006, targets Friedreich ataxia cardiomyopathy. The company is publicly traded on Nasdaq...
Biotechnology
Open roles
1
Founded
2017
Type
Public
Team size
51–200
Headquarters
New York, United States
Website
lexeotx.com
View on LinkedIn →
Open roles at Lexeotx
1 open rolesSubscribe to Career Resources.
Get the latest career advice, industry insights, and job opportunities delivered straight to your inbox.
